Comment on "Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?".

Authors

Manish R Bhise, Akshay Akotkar, Shweta Bhandari, Kuldip V Gite

Published in

Journal of cancer research and clinical oncology. Volume 152. Issue 9. Sep 07, 2026. Epub Sep 07, 2026.

PMID:
42706433
Bibliographic data and abstract were imported from PubMed on 08 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.